Cardiff Oncology, Inc. (CRDF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cardiff Oncology, Inc. on March 10, 2023. The company is a Delaware corporation with its principal executive offices in San Diego, CA, and its common stock trades on the Nasdaq Capital Market under the symbol CRDF.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report is limited to a specific disclosure regarding bank deposits.
Material Changes and Disclosure
Under Item 7.01 (Regulation FD Disclosure), the company confirmed that it does not hold cash deposits or securities at Silicon Valley Bank. This disclosure was made in the context of the banking sector instability occurring at the time of the filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general business risks beyond the specific confirmation regarding Silicon Valley Bank exposure. No unusual items or contingencies were reported in this document.
Investor Verification Checklist
- Verify the company's total cash and cash equivalents balance in the most recent 10-Q or 10-K to assess overall liquidity.
- Confirm the specific financial institutions where the company holds its cash deposits.
- Review subsequent filings for any updates on the company's financial position or operational status.